Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons

Pas encore traduit Pas encore traduit
Catégorie Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2012
Loading references information

CRD SUMMARY:

This generally well-conducted review concluded that higher efficacy in prevention of symptomatic venous thromboembolism in new anticoagulants following total knee or hip replacement was associated with a higher risk of bleeding. This conclusion accurately reflects the evidence and is likely to be reliable.
Epistemonikos ID: 8ec72a45ab2feaec5bee920113d9072425f4fdbc
First added on: Jan 13, 2015